Navigation Links
Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results
Date:6/11/2009

HAE:TSX

MONTREAL, June 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) released today the results of its second quarter ended April 30, and reports on its recently concluded strategic collaboration with Angiotech Pharmaceuticals, Inc.

Stategic Collaboration

As previously announced on June 3, 2009, Angiotech Pharmaceuticals, Inc. and Haemacure have entered into a strategic collaboration which provides Angiotech with license, distribution and supply rights related to Haemacure's all-human fibrin sealant and thrombin products, both of which are currently in development.

Bridge Financing

Also on June 3, 2009, Angiotech and Haemacure entered into a bridge loan agreement in the minimum amount of US$2.5 million, to be advanced by Angiotech in multiple draw-downs. An amount of US$200,000 was received upon the signing of a term sheet on May 1st, 2009 and an amount of US$1 million was received upon the closing of the transaction. Angiotech may, at its sole discretion, advance up to an additional US$1 million to Haemacure from time to time, in multiple draw-downs, for a total loan of US$3.5 million. Haemacure estimates that the loan of US$2.5 million will allow it to continue operations until the end of calendar 2009.

"We believe this strategic collaboration and bridge financing with Angiotech provide an important validation of our company and its product candidates. This also positions us for a larger, subsequent capital raise in order to complete the development and launch our fibrin sealant and thrombin products on the market, said Joseph Galli, Chairman and Chief Executive Officer of Haemacure. "By collaborating with Angiotech, a company with a successful track record of innovation in drug delivery, we are expanding the number of product candidates that can be developed and leveraging our technology in new markets with significant unmet needs" concluded Mr. Gal
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacures All-Human Fibrin Sealant and Thrombin Products
2. Haemacure Update on Proposed Collaboration and Bridge Financing
3. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
4. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
5. Haemacure Restructures - Seeks Financing or Sale of the Company
6. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
7. Haemacure Announces Fiscal 2008 Results
8. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
9. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
10. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
11. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... and alleviates muscle soreness after exercise, according to ... Illinois at Chicago. , The study, reported online ... of Physical Medicine and Rehabilitation , also showed ... had not exercised, suggesting that massage has benefits ... activity. , Improved circulation and relief of muscle ...
(Date:4/17/2014)... they suffer a cardiac arrest outside of a hospital ... to new research conducted at St. Michael,s Hospital. , ... arrest get adrenaline, which has been the drug recommended ... Lin, an emergency physician and trauma team leader at ... survival rates of patients who suffer a cardiac outside ...
(Date:4/16/2014)... the marvel of the embryo. It begins as a glob ... multiply to become the cells of our lungs, muscles, nerves ... Now, in a feat of reverse tissue engineering, Stanford University ... allows embryonic cells to proliferate and transform into all of ...
(Date:4/16/2014)... April 16, 2014 According to a new ... average-risk patients with one to two small polyps are ... cases. This may be an appropriate target for quality ... to quantify adherence to guidelines for timing of repeat ...
(Date:4/15/2014)... CHAMPAIGN, Ill. Scientists have solved a decades-old medical mystery ... to fight invasive fungal infections, which kill about 1.5 million people ... action of amphotericin, an antifungal drug that has been in use ... as toxic to human cells as it is to the microbes ...
Breaking Medicine News(10 mins):Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3
... Ind. - While biometric equipment is gaining popularity in ... to buildings, industries are finding that many users believe ... germs that could cause illness. , But a Purdue ... surfaces of devices that scan fingerprints or hand geometry ...
... In addition to the Spa, Six Signature Spa Suites Make Their ... Moon, the Caribbean,s Most Complete ... of Jamaica, the Honourable Bruce Golding, cut the ribbon to signal,the ... The Oct. 6 event marked the conclusion of a 15-month ...
... Department of,Veterans Affairs (VA) will augment its world-class ... grant received today from the Lilly Endowment,Inc. ... the Richard L. Roudebush VA Medical Center to ... from Iraq and Afghanistan and other,projects, including a ...
... news on research and advocacy reaches niche communities on ... RESTON, Va., Oct. 10 Voxant, the New ... 43,000 news videos,articles, and images dedicated to health news, ... Awareness month, and Voxant,has over 1,500 news assets that ...
... nutrition, physical activity and grieving programs, PITTSBURGH, ... than $580,000 in grants to four non-profit organizations,through ... will be used for,nutrition and physical activity programs ... program in Centre, Huntingdon and Mifflin counties. ...
... announced today that,their client, Critical Access HealthCare LLC ... critical access hospital in Borger,Texas. Ziegler Healthcare Consulting ... Under the terms of the Sept. 30 ... Golden Plains Community Hospital -- except for the ...
Cached Medicine News:Health News:Biometric sensors no dirtier than doorknobs, study finds 2Health News:Biometric sensors no dirtier than doorknobs, study finds 3Health News:Fern Tree, The Spa at Half Moon, Jamaica's Premier Spa, Opens With Ceremonial Ribbon Cutting 2Health News:Fern Tree, The Spa at Half Moon, Jamaica's Premier Spa, Opens With Ceremonial Ribbon Cutting 3Health News:Lilly Grant to VA Will Enhance Services for Returning Combat Veterans 2Health News:Voxant, the New Media Network, Distributes More Than 43,000 Health News Videos, Articles and Images 2Health News:Voxant, the New Media Network, Distributes More Than 43,000 Health News Videos, Articles and Images 3Health News:The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations 2Health News:The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations 3Health News:The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations 4Health News:Ziegler Client, Critical Access HealthCare LLC, Acquires Texas Hospital 2Health News:Ziegler Client, Critical Access HealthCare LLC, Acquires Texas Hospital 3Health News:Ziegler Client, Critical Access HealthCare LLC, Acquires Texas Hospital 4
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: